001     281733
005     20251013094700.0
024 7 _ |a 10.1038/s41588-025-02290-3
|2 doi
024 7 _ |a pmid:40926087
|2 pmid
024 7 _ |a 1061-4036
|2 ISSN
024 7 _ |a 1546-1718
|2 ISSN
037 _ _ |a DZNE-2025-01166
041 _ _ |a English
082 _ _ |a 570
100 1 _ |a Yépez, Vicente A
|0 0000-0001-7916-3643
|b 0
245 _ _ |a The Solve-RD Solvathons as a pan-European interdisciplinary collaboration to diagnose patients with rare disease.
260 _ _ |a London
|c 2025
|b Macmillan Publishers Limited, part of Springer Nature
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1760341371_8168
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Despite advances in genomic diagnostics, the majority of individuals with rare diseases remain without a confirmed genetic diagnosis. The rapid emergence of advanced omics technologies, such as long-read genome sequencing, optical genome mapping and multiomic profiling, has improved diagnostic yield but also substantially increased analytical and interpretational complexity. Addressing this complexity requires systematic multidisciplinary collaboration, as recently demonstrated by targeted diagnostic workshops. Here, we highlight the experience of the Solve-RD consortium, a pan-European initiative, in implementing four structured workshops, termed 'Solvathons', as a regular and effective component of its operational workflow. We provide actionable insights, best practices and lessons learned for successful data integration, expert training and scalable collaborative diagnostics within large research consortia.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 2 |a Rare Diseases: diagnosis
|2 MeSH
650 _ 2 |a Rare Diseases: genetics
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Europe
|2 MeSH
650 _ 2 |a Genomics: methods
|2 MeSH
650 _ 2 |a Genetic Testing: methods
|2 MeSH
700 1 _ |a Demidov, German
|0 0000-0001-9075-4276
|b 1
700 1 _ |a Ellwanger, Kornelia
|0 0000-0003-4845-5795
|b 2
700 1 _ |a Laurie, Steven
|0 0000-0003-3913-5829
|b 3
700 1 _ |a Luknárová, Rebeka
|0 0009-0009-9987-8879
|b 4
700 1 _ |a Joseph Maran, Midhuna Immaculate
|b 5
700 1 _ |a Hentrich, Thomas
|0 0000-0002-1488-9096
|b 6
700 1 _ |a Sagath, Lydia
|b 7
700 1 _ |a van der Sanden, Bart
|0 0000-0003-0546-1351
|b 8
700 1 _ |a Astuti, Galuh
|b 9
700 1 _ |a Neveling, Kornelia
|0 0009-0000-8055-5329
|b 10
700 1 _ |a Batlle-Masó, Laura
|b 11
700 1 _ |a Beijer, Danique
|0 P:(DE-2719)9002605
|b 12
|u dzne
700 1 _ |a Brechtmann, Felix
|0 0000-0002-0110-152X
|b 13
700 1 _ |a Caballero-Oteyza, Andrés
|0 0000-0002-8892-1255
|b 14
700 1 _ |a Dabad, Marc
|0 0000-0002-6094-747X
|b 15
700 1 _ |a Denommé-Pichon, Anne-Sophie
|0 0000-0002-8986-8222
|b 16
700 1 _ |a Doornbos, Cenna
|b 17
700 1 _ |a Eddafir, Zakaria
|0 0009-0008-9648-5984
|b 18
700 1 _ |a Estévez-Arias, Berta
|b 19
700 1 _ |a Kilicarslan, Ozge Aksel
|b 20
700 1 _ |a Kolen, Ingrid H M
|0 0009-0001-1483-8328
|b 21
700 1 _ |a Kraß, Leon
|0 0009-0008-9547-1871
|b 22
700 1 _ |a Lohmann, Katja
|b 23
700 1 _ |a Londhe, Shubhankar
|0 0000-0002-1220-6650
|b 24
700 1 _ |a López-Martín, Estrella
|0 0000-0003-3212-1424
|b 25
700 1 _ |a Maassen, Kars
|0 0000-0001-7086-0637
|b 26
700 1 _ |a Macken, William
|0 0000-0003-0612-5819
|b 27
700 1 _ |a Martínez-Delgado, Beatriz
|0 0000-0001-6834-350X
|b 28
700 1 _ |a Mei, Davide
|0 0000-0001-6790-6251
|b 29
700 1 _ |a Mertes, Christian
|0 0000-0002-1091-205X
|b 30
700 1 _ |a Minardi, Raffaella
|b 31
700 1 _ |a Morsy, Heba
|0 0000-0002-9047-0959
|b 32
700 1 _ |a Mueller, Juliane S
|b 33
700 1 _ |a Natera-de Benito, Daniel
|0 0000-0001-7764-2085
|b 34
700 1 _ |a Nelson, Isabelle
|b 35
700 1 _ |a Oud, Machteld M
|0 0000-0003-4864-9346
|b 36
700 1 _ |a Paramonov, Ida
|b 37
700 1 _ |a Picó, Daniel
|0 0000-0001-5254-2184
|b 38
700 1 _ |a Piscia, Davide
|b 39
700 1 _ |a Polavarapu, Kiran
|b 40
700 1 _ |a Raineri, Emanuele
|b 41
700 1 _ |a Savarese, Marco
|b 42
700 1 _ |a Smal, Noor
|b 43
700 1 _ |a Steehouwer, Marloes
|0 0009-0000-5177-7803
|b 44
700 1 _ |a Steyaert, Wouter
|b 45
700 1 _ |a Swertz, Morris A
|b 46
700 1 _ |a Thomsen, Mirja
|b 47
700 1 _ |a Töpf, Ana
|b 48
700 1 _ |a Van de Vondel, Liedewei
|0 0000-0003-2214-5908
|b 49
700 1 _ |a van der Vries, Gerben
|b 50
700 1 _ |a Vitobello, Antonio
|0 0000-0003-3717-8374
|b 51
700 1 _ |a Wilke, Carlo
|0 P:(DE-2719)2814101
|b 52
|u dzne
700 1 _ |a Zurek, Birte
|b 53
700 1 _ |a DITF-EPICARE, Solve-RD
|b 54
|e Collaboration Author
700 1 _ |a DITF-ITHACA, Solve-RD
|b 55
|e Collaboration Author
700 1 _ |a DITF-EURO-NMD, Solve-RD
|b 56
|e Collaboration Author
700 1 _ |a DITF-RITA, Solve-RD
|b 57
|e Collaboration Author
700 1 _ |a DITF-RND, Solve-RD
|b 58
|e Collaboration Author
700 1 _ |a consortium, Solve-RD
|b 59
|e Collaboration Author
700 1 _ |a T' Hoen, Peter-Bram
|0 0000-0003-4450-3112
|b 60
700 1 _ |a Matalonga, Leslie
|b 61
700 1 _ |a Vissers, Lisenka E L M
|0 0000-0001-6470-5497
|b 62
700 1 _ |a Gilissen, Christian
|0 0000-0003-1693-9699
|b 63
700 1 _ |a Schulze-Hentrich, Julia
|b 64
700 1 _ |a Beltran, Sergi
|b 65
700 1 _ |a Esteve-Codina, Anna
|0 0000-0003-0361-2873
|b 66
700 1 _ |a Hoischen, Alexander
|0 0000-0002-8072-4476
|b 67
700 1 _ |a Gagneur, Julien
|0 0000-0002-8924-8365
|b 68
700 1 _ |a Graessner, Holm
|0 0000-0001-9803-7183
|b 69
773 _ _ |a 10.1038/s41588-025-02290-3
|g Vol. 57, no. 10, p. 2361 - 2370
|0 PERI:(DE-600)1494946-5
|n 10
|p 2361 - 2370
|t Nature genetics
|v 57
|y 2025
|x 1061-4036
856 4 _ |u https://pub.dzne.de/record/281733/files/DZNE-2025-01166_Restricted.pdf
856 4 _ |u https://pub.dzne.de/record/281733/files/DZNE-2025-01166_Restricted.pdf?subformat=pdfa
|x pdfa
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 12
|6 P:(DE-2719)9002605
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 52
|6 P:(DE-2719)2814101
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2025-01-01
|w ger
915 _ _ |a DEAL Nature
|0 StatID:(DE-HGF)3003
|2 StatID
|d 2025-01-01
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2025-01-01
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2025-01-01
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2025-01-01
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2025-01-01
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2025-01-01
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2025-01-01
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2025-01-01
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2025-01-01
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2025-01-01
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NAT GENET : 2022
|d 2025-01-01
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2025-01-01
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2025-01-01
915 _ _ |a IF >= 30
|0 StatID:(DE-HGF)9930
|2 StatID
|b NAT GENET : 2022
|d 2025-01-01
920 1 _ |0 I:(DE-2719)1210000
|k AG Gasser
|l Parkinson Genetics
|x 0
980 _ _ |a journal
980 _ _ |a EDITORS
980 _ _ |a VDBINPRINT
980 _ _ |a I:(DE-2719)1210000
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21